LAKE FOREST, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, will host investor meetings September 14, 2022 as part of the Lake Street Capital Markets Best Ideas Growth Conference (BIG6), taking place at The Yale Club in New York City.
As part of the conference event, management will host one-on-one meetings throughout the day.
For more information about scheduling a one-on-one meeting with management, please contact your Lake Street representative or Matt Kreps, Investor Relations for Assertio Holdings, at mkreps@darrowir.com.
About Assertio
Assertio Holdings, Inc. is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. For more information regarding Assertio Holdings, go to: https://www.assertiotx.com/.
Investor Contact:
Matt Kreps
Managing Director
Darrow Associates
Austin, TX
M: 214-597-8200
mkreps@darrowir.com
Omni-Biotic, an award-winning leader in probiotic supplements from Austria, is launching Omni-Biotic Power in the…
NORTHAMPTON, MA / ACCESSWIRE / June 10, 2024 / Akoi Dau Pawol was born and…
SECAUCUS, NJ / ACCESSWIRE / June 10, 2024 / Quest Diagnostics (NYSE:DGX), a leading provider…
COLUMBIA, MD / ACCESSWIRE / June 10, 2024 / Nava Health, a leader in longevity,…
AI Model Designed to Guarantee Accuracy & Avoid HallucinationsPALO ALTO, Calif.--(BUSINESS WIRE)--Harmonic, an artificial intelligence…
DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine and NI Medical are pleased to announce they will be presenting a…